Aesthetic Medical International Holdings Group Limited EBIT

The latest EBIT for PAIYY is $-60M as of December 2023. That compares with $-73M in the prior-year period — up 17.9% year over year. That is below the Healthcare sector average of $130B. Investors often review this figure alongside Aesthetic Medical International Holdings Group Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, PAIYY's EBIT moved from $-73M to $-60M — a 17.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aesthetic Medical International Holdings Group Limited's operating scale or balance-sheet position.

Against Healthcare companies, PAIYY currently prints $-60M for EBIT, while the sector average sits near $130B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Aesthetic Medical International Holdings Group Limited's growth, margins, and balance sheet.

A EBIT figure of $-60M for PAIYY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $130B. Explore the charts below for those layers of context.

After noting PAIYY's EBIT ($-60M), review year-over-year change from $-73M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.